Bormioli Pharma will attend Pharmapack Europe in Paris, unveiling its new brand identity


Based on the concept “Small part, Big Impact”, the new identity reflects the company’s “new wave”.

Among the pillars of this drive for change, Bormioli Pharma is rolling out a new innovation model featuring a more open, distributed approach, the unification of corporate marketing and innovation functions, as well as a growing attention to consumers’ needs and market trends and the presentation of products in an innovative way.

Fidenza, Italy, 22nd January 2019 - Bormioli Pharma, leading global producer in the pharma packaging market, will attend to Pharmapack Europe, the leading European event for pharmaceutical packaging, drug delivery, medical devices and machinery, connecting pharma packaging producers and clients. The trade fair will take place at Paris Expo, Porte de Versailles, the French capital’s exhibition center, on 6th and 7th February.

The firm’s management will be on hand at the booth A66 of the fair to meet the stakeholders and discuss the company’s growth plans and innovative projects.

In a pharmaceutical market in which the drive for change is getting increasingly stronger, the company is implementing a five-year strategic plan, that has among its pillars – together with the company’s internationalization, the enhancement of efficiency of existing platforms and the increase of productivity - the design of a new model of innovation, a considerable drive that leverages on four columns:

  • A more open, distributed approach, integrating internal R&D projects with start-ups and incubators – such as Le Village by Crédit Agricole – and involving clients and final users to achieve a big impact from true innovations
  • A new disruptive corporate structure, unifying marketing and innovation functions to better intercept the needs and trends of the market and to ensure a faster go-to-market
  • A growing attention to intercept new consumers’ needs – putting patients at the center of the stage - and external trends, such as digital and sustainability.
  • Presenting the products in a new, innovative way. A first example will beshown at Pharmapack Europe, with a brand-new experience offered to visitors with an interactive installation curated by the Italian architect and innovator Carlo Ratti.

The new brand identity – unveiled for the first time during PharmaPack Europe - will be the manifesto of this new Bormioli Pharma, giving life to the very concept that animates everyday’s company behavior: Small part, Big impact.  This means striving for perfection and continue innovation, aware that the difference between a great success and failure stays in detail, always with the aim of putting the health in the hands of patients.

About Bormioli Pharma:
Bormioli Pharma operates in close partnership with the pharmaceutical industry and with all the businesses that are engineering the future of healthcare. As a world-renowned player in the packaging industry, Bormioli Pharma serves the pharmaceutical and biopharmaceutical market with integrated glass and plastic containers, closures, and packaging accessories using state-of-the-art materials and technologies.
Each product is a unique combination of rigorous studies, cutting-edge technology, extreme testing, advanced industrial processes, and the finest materials.As a partner to the pharmaceutical industry, Bormioli Pharma invests and innovates with one goal in mind: improving people’s lives. Bormioli Pharma employees over 900 people, produces 5 billion pieces in glass and plastic, and has an annual turnover of approximately €220 million in 2017.

For more information:
Bormioli Pharma Press Office
Hill+Knowlton Strategies

Daniele Rurale – +39 346 5011546 – [email protected]
Ivan Martelli – +39 342 0723104 – [email protected]